Work

Ripretinib as preoperative therapy in patients with potentially resectable advanced gastrointestinal stromal tumors after imatinib failure: Final analysis of a prospective, multicenter study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11537

Authors: Linxi Yang, Xiaodong Gao, Tianyu Lin, Qiang Zhang, Ye Zhou, Xiaofeng Sun, Xiangfei Sun, Zizhen Zhang, Hui Cao, Hao Xu, Haoran Qian, Kuntang Shen, Ming Wang

Institutions: Shanghai Jiao Tong University, Renji Hospital, Shanghai Medical College of Fudan University, Fudan University, Zhongshan Hospital, Sir Run Run Shaw Hospital, Zhejiang University, Jiangsu Province Hospital, Fudan University Shanghai Cancer Center, Nanjing Medical University

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162513751

Cites:

Cited by:

Related to: